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Key points
 Channelopathies of autoimmune origin are novel and are associated with corrected QT (QTc)
prolongation and complex ventricular arrhythmias.
 We have recently demonstrated that anti-SSA/Ro antibodies from patients with autoimmune
diseases and with QTc prolongation on the ECG target the human ether-a`-go-go-related
gene (HERG) K+ channel by inhibiting the corresponding current, IKr, at the pore
region.
 Immunizationof guinea-pigswithapeptide (E-porepeptide) corresponding to the extracellular
loop region connecting the S5 and S6 segments of the HERG channel induces high titres of
antibodies that inhibit IKr, lengthen the action potential and cause QTc prolongation on
the surface ECG. In addition, anti-SSA/Ro-positive sera from patients with connective tissue
diseases showed high reactivity to the E-pore peptide.
 The translational impact is the development of a peptide-based approach for the diagnosis and
treatment of autoimmune-associated long QT syndrome.
Abstract We recently demonstrated that anti-SSA/52 kDa Ro antibodies (Abs) from patients
with autoimmune diseases and corrected QT (QTc) prolongation directly target and inhibit the
human ether-a`-go-go-related gene (HERG) K+ channel at the extracellular pore (E-pore) region,
where homology with SSA/52 kDa Ro antigen was demonstrated. We tested the hypothesis
that immunization of guinea-pigs with a peptide corresponding to the E-pore region (E-pore
peptide) will generate pathogenic inhibitory Abs and cause QTc prolongation. Guinea-pigs were
immunized with a 31-amino-acid peptide corresponding to the E-pore region of HERG. On
days 10–62 after immunization, ECGs were recorded and blood was sampled for the detection of
E-pore peptide Abs. Serum samples from patients with autoimmune diseases were evaluated for
reactivity to E-pore peptide by enzyme-linked immunosorbent assay (ELISA), and histology was
performed on hearts using Masson’s Trichrome. Inhibition of the HERG channel was assessed
by electrophysiology and by computational modelling of the human ventricular action potential.
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The ELISA results revealed the presence of high titres of E-pore peptide Abs and significant QTc
prolongation after immunization. High reactivity to E-pore peptide was found using anti-SSA/Ro
Ab-positive sera from patients with QTc prolongation. Histological data showed no evidence of
fibrosis in immunized hearts. Simulations of simultaneous inhibition of repolarizing currents
by anti-SSA/Ro Ab-positive sera showed the predominance of the HERG channel in controlling
action potential duration and the QT interval. These results are the first to demonstrate that
inhibitory Abs to the HERG E-pore region induce QTc prolongation in immunized guinea-pigs
by targeting the HERG channel independently from fibrosis. The reactivity of anti-SSA/Ro
Ab-positive sera frompatients with connective tissue diseases with the E-pore peptide opens novel
pharmacotherapeutic avenues in the diagnosis and management of autoimmune-associated QTc
prolongation.
(Received 15 January 2016; accepted after revision 1 June 2016; first published online 14 June 2016)
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Introduction
Autoantibody-associated cardiac channelopathies are
gaining significant interest in the area of heart rhythm
disturbances (Qu & Boutjdir 2012; Xiao et al. 2012;
Li et al. 2013, 2014; El-Sherif & Boutjdir, 2015).
In a series of papers, we identified L-type Ca2+
channel-inhibiting (antagonist-like) antibodies (Abs)
directed against the extracellular loop domain as crucial
in the pathophysiology of congenital heart block (Boutjdir
et al. 1997, 1998; Qu et al. 2001, 2005; Karnabi et al.
2010, 2011). Activating (agonist-like) Abs against Ca2+
and K+ channels have also been reported in dilated
cardiomyopathy (Xiao et al. 2012) and the short QT
syndrome (Li et al. 2013, 2014), respectively. In particular,
immunization of rabbits with KCNQ1-encoded Kv7.1 K+
channel peptide induced high circulating anti-KCNQ1
antibody titres and accelerated cardiac repolarization as
a result of an activating effect on the related IKs current
(Li et al. 2014). Moreover, an autoimmune-mediated
inhibition or activation of Ca2+ and K+ channels can also
be the indirect result of Abs that recognize cardiac anti-
gens, such as the β1-adrenergic receptor, as observed in
patients with dilated cardiomyopathy (Christ et al. 2001;
Fukuda et al. 2004; Lazzerini et al. 2015). Notably, only
rabbit immunization with the second extracellular loop
of the human β1-adrenergic receptor induced functional
Abs, whereas Abs resulting from the immunization
with the extracellular N-terminus had no functional
effects (Magnusson et al. 1994). Thus, depending on the
specific cardiac antigen considered and the fine epitope
specificity of the peptide employed, immunization can
unpredictably induce activating (agonist-like), inhibiting
(antagonist-like) or non-functional Abs.
A novel acquired autoimmune-associated long QT
syndrome has recently been reported in adult patients
carrying anti-SSA/52 kDa Ro (anti-Ro52) Abs (Lazzerini
et al. 2004, 2007, 2008; Bourre-Tessier et al. 2011).
Clinically, patients with connective tissue diseases who
tested positive for anti-Ro52 Abs had a prolonged
corrected QT (QTc) and complex ventricular arrhythmias
independent of any other QTc-prolonging factors, such as
medication, electrolytes or genetic factors (Lazzerini et al.
2004). The molecular and functional basis for this QTc
prolongationhas been attributed to a functional inhibition
of the human ether-a-go-go-related gene (HERG) channel
conducting the rapidly activating delayed K+ current, IKr
(Nakamura et al. 2007), by direct interaction of the anti-
bodies with the extracellular loop between segments S5
and S6 of the pore-forming α1 subunit of the HERG
channel (Yue et al. 2015; Lazzerini et al. 2016). In the pre-
sent study, we tested the hypothesis that immunization
of guinea-pigs with a peptide corresponding to the
extracellular pore region (E-pore peptide) of the α1 sub-
unit of HERG will be sufficient to inhibit but not activate
IKr, thus resulting in action potential duration (APD)
lengthening and in QTc prolongation on the surface ECG.
Methods
Ethical approval
The experiments used heart tissue from isoflurane-
anaesthetized Dunkin–Hartley adult guinea-pigs. All
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animal procedures were performed in conformity with
the US National Institutes of Health guidelines for care
and use of laboratory animals and the local institutional
animal care and use committee at the VA New York
Harbor Healthcare System, New York. The investigators
understand the ethical principles under which the journal
operates, and this work complies with animal ethics
checklist.
Synthesis of E-pore peptides and immunization
Given that the Ro52 antigen is not accessible to circulating
Abs, we hypothesized that circulating anti-Ro Abs must
recognize an epitopemimic on the extracellular side of the
HERG channel homologous to Ro52 antigen. Homology
analysis showed the presence of homology between the
Ro52 antigen at the extracellular pore region of the HERG
channel (Fig. 1). We thus designed the E-pore peptide
(GNMEQPHMDSRIGWLHNLGDQIGKPYNSSGL) and
the scrambled peptide (NEQDRSGYHPMKWMSIIL-
GGSGLNGPQNDLH), which were synthesized at >90%
purity by Genscript USA, Inc., (Piscataway, NJ, USA).
The E-pore peptide consisted of a 31-amino-acid
sequence corresponding to a portion of the 65-amino-acid
extracellular loop between S5 and S6 of the pore-forming
region of the α1 subunit of the HERG channel where
homology with Ro52 antigen exists (Fig. 1). Six- to
8-week-old Dunkin–Hartley guinea-pigs (n = 10; four
males and six females) were immunized with 75 μg of the
peptide in complete Freund’s adjuvant subcutaneously in
the scapular region (Boutjdir et al. 1997; Miranda-Carus
et al. 1998; Xiao et al. 2001b; Karnabi et al. 2011; Yue
et al. 2015). Subsequent booster injections of 37.3 μg
in incomplete Freund’s adjuvant were administered 10
and 15 days after the initial immunization. Control
experiments were conducted in six guinea-pigs using
the same immunization protocol but with the scrambled
peptide. Guinea-pigs were anaesthetized using a Minivent
ventilator attached to an isoflurane vapourizer (Harvard
Apparatus, Holliston, MA, USA).
Electrocardiographic recordings
The ECG was recorded in lead II at baseline (before
immunization) and on days 10, 21, 32, 42, 48 and 62
after immunization. The ECGs were analysed for QTc,
heart rate, PR and QRS intervals. The QTc was calculated
using Bazett’s formula because it is more suitable for
anaesthetized guinea-pigs (Hamlin et al. 2003).
Blood collection
Blood was obtained via the cranial vena cava while the
animals were under general anaesthesia on days 0, 10, 21,
42 and 62. The serum was isolated by centrifugation for
20 min at 5000 g, and an enzyme-linked immunosorbent
assay (ELISA) was used to detect the antibody levels (Yue
et al. 2015).
Enzyme-linked immunosorbent assay
An ELISA was used for the detection of antibody levels
(Yue et al. 2015). The peptide (E-pore or scrambled) was
coated overnight, washed in PBS–Tween 20 and probed
in diluted serum followed by anti-human immuno-
globulin G (IgG) alkaline phosphatase. The plates were
developed with disodium p-nitrophenyl phosphate. All
samples were run in triplicate. Results were expressed as
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Figure 1. Homology between HERG K+ channel
and Ro52 protein
A, relevant linear homology between Ro52 protein
and HERG channel at the pore region. B, schematic
representation of the secondary structure of a single
HERG channel α1 subunit. The six segments (S1–S6)
are shown, along with the intracellularly located N-
and C-termini. The pore-forming extracellular loop is
located between S5 and S6, where black and blue
circles illustrate similar and identical amino acids
between Ro52 protein and HERG channel,
respectively. C, schematic illustration of the top view
of the tetrameric HERG channel, bringing together the
homologous regions at the pore.
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the optical density at 405 nm minus that of the reagent
blank.
Electrophysiological studies
Expression systems. HEK293 cells stably expressing the
HERG channel were a generous gift fromDrCraig January
(University of Wisconsin, Madison, WI, USA) and Dr
Zhengfeng Zhou (Oregon Health & Science University,
Portland, OR, USA). Details of DNA constructs and
the methods of stable transfection of HEK293 cells with
HERG channel have been reported elsewhere (Zhou et al.
1998). These HEK293 cells were cultured in minimal
essential medium (MEM) supplemented with 10% fetal
bovine serum and 400 μg ml−1 geneticin (G418). Cells
were washed twice with standard MEM, and stored in
this medium at room temperature for later use. Cells
were superfused with Hepes-buffered Tyrode’s solution
containing (mM): 137 NaCl, 4 KCl, 1.8 CaCl2, 1 MgCl2, 10
glucose and 10 Hepes (pH adjusted to 7.4 with NaOH).
The internal pipette solution contained (mM): 130 KCl,
1 MgCl2, 5 EGTA, 5 MgATP and 10 Hepes (pH adjusted
to 7.2 with KOH). The IKr was recorded using a standard
protocol (shown in Fig. 3F) as previously reported (Yue
et al. 2015; Lazzerini et al. 2016). Experiments were
performed at room temperature.
Guinea-pig ventricular myocytes. Guinea-pigs were
anaesthetized with isoflurane using a Harvard apparatus
vapourizer, and animals weremonitored until recumbent.
A thoracotomy was performed and the heart rapidly
excised and, in this way, the animal was killed. Hearts were
then Langendorf perfused with Tyrode’s solution of the
following composition (mM): 140 NaCl, 4.5 KCl, 2 CaCl2,
10 dextrose, 1 MgCl2 and 10 Hepes (pH 7.4) for 2 min.
The heart was then perfused with Ca2+-free Tyrode’s
solution followed by collagenase B (final concentration,
0.6 mg ml−1; Worthington, Lakewood, NJ, USA). The
dispersed cells were resuspended in Kraft-Bru¨he (KB)
solution and maintained at room temperature before use.
The external solution used for IKr recordings contained
(mM): 145 NaCl, 4.5 KCl, 1 MgCl2, 1.8 CaCl2, 10 Hepes
and 10 glucose (pH 7.35). Calcium currents were blocked
by the addition of 10 μM nifedipine in the bath solution,
and the slow delayed rectifier K+ current (IKs) was blocked
with 10 μM chromanol. The pipette solution contained
(mM): 140 KCl, 10 Hepes, 11 EGTA, 1 MgCl2, 1 CaCl2,
5 MgATP and 5 K2ATP; the pH was adjusted to 7.2
with KOH. Currents were recorded in the whole-cell,
voltage-clampconfigurationof thepatch-clamp technique
using an Axopatch-200B amplifier (Axon Instruments,
Inc., Burlingame, CA, USA). The IKr was recorded using a
short (200ms) depolarizing pulse fromaholding potential
of −40 mV, and test pulses were applied at various
voltages from −40 to +40 mV in 10 mV increments
before returning to −40 mV for tail current recording
(Yue et al. 2015; Lazzerini et al. 2016).Measurements were
repeated every 2 min to allow for complete tail current
deactivation. Action potentials were recorded from
single ventricular myocytes in current-clamp mode by
passing depolarizing currents at subthreshold (1.4 times)
intensity.
Histology and quantification of myocardial fibrosis
Hearts were washed in PBS, fixed in 10% neutral buffered
formalin, and embedded in paraffin as described pre-
viously (Wolf et al. 2005). Transverse serial sections 5 μm
thick were cut every 50 μm from the apex to the base
of the hearts and stained with Masson’s Trichrome to
assess collagen deposition resulting from fibrosis. Fibrotic
areas within sections were measured as blue-stained areas,
exclusive of staining that co-localized with perivascular
or intramural vascular structures, the endocardium or
left ventricular trabeculae (Wolf et al. 2005). Blue-stained
areas and non-stained myocyte areas from each section
were determined with a colour-based threshold using
ImageJ software (National Institutes of Health, Bethesda,
MD, USA). The total fibrotic area was calculated as
the summed blue-stained areas divided by the total
ventricular area and expressed as a percentage (Wolf et al.
2005).
Computational modelling
Simulations of the human ventricular action potential
(AP) and pseudo-ECG were performed using the model
developed by O’Hara et al. (2011), with the incorporation
of a cell cable in the model to produce traces similar to the
pseudo-ECG in humans using MATLAB programming
language. The heterogeneity of ionic conductances seen
across the epi-, mid- and endocardial cell layers was
incorporated according to their specifications; the size
of the wall and the relative size of each layer were
constructed according toGima&Rudy (2002). Simulation
of alterations in IKr, IKs and L-type Ca current (ICaL) were
achieved by changing the conductance values of GKr, GKs
and GCaL by the corresponding percentage inhibition as
appropriate.
Data and statistical analyses
The ECGs were analysed using LabChart Pro software
(AD Instruments, Inc., Colorado Springs, CO, USA).
Statistical comparisons at baseline and after interventions
were evaluated with Student’s paired t test and with the
non-parametricWilcoxon paired test as appropriate using
Origin9.1 (OriginLab Corporation, Northampton, MA,
USA). Data are presented as means ± SD. A value of
P < 0.05 was considered significant.
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Results
Immunization with the peptide corresponding
to the extracellular pore region of the HERG channel
induced QTc prolongation in guinea-pigs
Electrocardiograms were performed on 16 guinea-pigs
(10 experimental and 6 control) at baseline and at
several time points after immunization. In the E-pore
peptide-immunized guinea-pigs, the average QTc was
263 ± 4 ms at baseline and 312 ± 5 ms on day 62
(P = 0.0001), an increase of 49 ms. This QTc prolon-
gation was associated with high titres of anti-E-pore
peptide Abs in immunized guinea-pigs (optical density
increased from0.02±0.01 at baseline to2.73±0.73onday
62, n= 10, P < 0.01), reflecting successful immunization.
There were no significant differences between heart rate,
PR and QRS intervals at baseline and after immunization.
Figure 2 illustrates an example of a guinea-pig ECG before
(Fig. 2A) and after immunization on day 62 (Fig. 2B).
The QTc values were 254 ms at baseline and 306 ms 62
days after E-pore peptide immunization, corresponding
to an increase in QTc of 54 ms. Control guinea-pigs
immunized with the scrambled E-pore peptide showed no
significant ECG changes compared with baseline except
for high antibody titres (optical density increased from
0.08 ± 0.01 at baseline to 1.36 ± 0.13 on day 62, n = 6,
P < 0.01). Figure 2C and D illustrates ECGs at baseline
and62days after scrambledE-porepeptide immunization,
respectively. Figure 2E shows that QTc values increased
progressively after immunization with E-pore peptide but
not with scrambled E-pore peptide. The levels of Abs also
increased after E-pore peptide immunization (Fig. 2F;
n = 10 for each time point) and the prolongation in
QTc correlated well with the antibody levels (Fig. 2G)
as assessed by the coefficient of determination (R2 = 0.81,
P < 0.01).
Serum from E-pore peptide-immunized guinea-pigs
inhibited IKr recorded from HEK293 cells
Figure 3 shows the effect of serum from E-pore
peptide-immunized guinea-pigs on IKr recorded from
HEK293 cells stably expressing HERG channels. This
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Figure 2. E-pore peptide immunized guinea-pigs exhibit QTc prolongation
Selected ECG from the same guinea-pig at baseline (pre-immunization; A) and after E-pore peptide immunization
(B). C and D represent a control ECG at baseline and an ECG 62 days after scrambled E-pore peptide-immunization,
respectively. E, QTc values before (n = 10) and after immunization of guinea-pigs (n = 10) with E-pore peptide
(squares) and scrambled E-pore peptide (circles) between days 10 and 62. F, enzyme-linked immunosorbent
assay values for anti-E-pore peptide antibodies at days between 0 and 62 (n = 10 at each time point). G, the
correlation between QTc prolongation and the anti-E-pore peptide antibody levels is illustrated by the coefficient
of determination, R2 (each data point represents the QTc and the corresponding optical density values at the days
shown in F).
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serum (100μl) inhibited IKr peak densities at 0mVby 23%
(from 48.2 ± 5.8 to 37.4 ± 6.5 pA pF−1, P < 0.05, n = 8)
and IKr tail densities by 23% (from 90.6± 5.0 to 70.3± 4.6
pA pF−1, P < 0.01, n = 8). These effects on IKr were not
seen with serum samples (100 μl) from non-immunized
guinea-pigs at baseline before immunization (IKr peak
densities at 0 mV from 45.3 ± 5.2 to 41.2 ± 5.3 pA pF−1,
P > 0.05, n = 6; IKr tail from 92.2 ± 7.4 to 88.4 ± 6.4
pA pF−1, P > 0.05, n = 6).
Serum from E-pore peptide-immunized guinea-pigs
inhibited IKr and prolonged the APD recorded
from cardiomyocytes
Figure 4 shows IKr recorded from guinea-pig ventricular
myocytes using a short-duration (200 ms) pulse protocol
from a holding potential of −40 mV, at which the slow
delayed rectifier, IKs, is inactive (and in the presence of 10
μM chromanol, an IKs blocker). Serum samples (100 μl)
from scrambled peptide-immunized control guinea-pigs
(n = 6) had no effect on IKr peak or tail currents (Fig. 4A
and C). However, sera from E-pore peptide-immunized
guinea-pigs significantly inhibited IKr peak by 27.6%
(P < 0.01, n = 6) and IKr tail by 29.0% (P < 0.01,
n = 6; Fig. 4B andD). If the QTc prolongation seen in the
immunized guinea-pigs is attributable to IKr inhibition,
then serum samples from immunized guinea-pigs should
be expected to lengthen the ventricular APD. Thus, action
potentials (APs) were recorded from guinea-pig single
ventricular myocytes before and after the application
of control and E-pore peptide-immunized guinea-pig
serum samples at 0.5 Hz in the current-clamp mode
configuration. Figure 4 shows that control serum samples
(100 μl) had no effect on AP parameters (Fig. 4E; n = 6)
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Figure 3. Serum from E-pore peptide immunized guinea-pigs inhibits IKr
A and B, representative current traces for IKr recorded from HEK293 cells stably expressing HERG channels at
baseline (A) and in the presence of serum (100 μl) from an E-pore peptide-immunized guinea-pig (B). C and D, I–V
relationships of IKr peak (C) and tail current densities (D) at baseline (circles) and after application of serum from
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after serum application from E-pore peptide-immunized guinea-pigs. F shows the protocol used to record IKr from
HEK293 cells stably expressing HERG channels. ∗Statistical significance at P < 0.05 (n = 8 each).
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and on the action potential at 90% duration (APD90;
Fig. 4G; n = 6). However, serum samples (100 μl)
from E-pore peptide-immunized guinea-pigs resulted in
a prolongation of APD90 by 30.0% (P < 0.01, n = 6)
without any changes in the resting membrane potential or
AP amplitude (Fig. 4F and H).
Serum from anti-Ro-positive patients immunoreacted
with the peptide corresponding to the extracellular
pore region of the HERG channel
Next, we tested whether serum samples from patients
with autoimmune diseases, mainly connective tissue
diseases, anti-Ro Ab positive and with documented QTc
prolongation (QTc >460 ms; Lazzerini et al. 2004, 2007),
would demonstrate reactivity to the E-pore peptide.
Patients with connective tissue diseases who were anti-Ro
Ab negative and with a normal QTc (<440 ms) were used
as a control group. Figure 5 depicts the reactivity status of
13 anti-Ro Ab-positive connective tissue disease patients
and eight anti-Ro Ab-negative connective tissue disease
patients. The difference in the average optical density
values, indicated by the squares in Fig. 5, was statistically
significant (P = 0.00029) between the positive group
(1.2 ± 0.1, n = 13) and the negative group (0.2 ± 0.002,
n= 8). The optical density values ranged from 0.51 to 2.47
in the positive group and from 0.10 to 0.41 in the negative
group.
Immunization of guinea-pigs with the peptide
corresponding to the extracellular pore region
of the HERG channel did not induce fibrosis
Although previous studies suggested that provocation
of an autoimmune response against ion channels can
induce electrophysiological changes without eliciting
an immune-mediated tissue inflammatory response
(Korkmaz et al. 2013; Li et al. 2014), it has been
demonstrated that other cardiac autoantibodies associated
with development of arrhythmias, such as anti-myosin
heavy chain autoantibodies, exert their pathological
effect by promoting an acute inflammatory response,
and resulting in later reparative myocardial fibrosis
(Lazzerini et al. 2008; Watanabe et al. 2011). To
test whether immunization with the E-pore peptide
might have resulted in myocardial fibrosis, we prepared
Masson’s Trichrome-stained sections from immunized
and non-immunized hearts. Figure 6 shows transverse
cross-sections of guinea-pig hearts across the ventricles
from a control non-immunized (Fig. 6A) and an E-pore
peptide immunized (Fig. 6B) guinea-pig at 62 days after
immunization. There was no significant difference in
fibrosis (blue staining) between the control and E-pore
peptide-immunized guinea-pig ventricles, although the
latter showed a slightly greater staining, which was not
statistically significant. The average quantification data
of fibrosis for the two groups are illustrated in Fig. 6C
25
0 
pA
500 ms
IKr peak IKr tail IKr tailIKr peak
0
400
300
200
100
0
400
∗
∗
∗
300
200
100
0
400
300
200
100
I K
r 
(p
A
)
I K
r 
(p
A
)
A
P
D
90
 (
m
s)
A
P
D
90
 (
m
s)
0
500
300
200
100
200 ms 
40
 m
V
400
A EB
GDC H
F
Baseline
Control
Sera 
Baseline
E-pore peptide
immunized
Sera  
Basal E-pore
Peptide
Immunized
Sera  
Basal Control
Sera 
Control
Sera 
E-pore peptide Immunized
Sera 
Control
Sera  
E-pore
peptide
Immunized
Sera    
Figure 4. E-pore peptide immunized guinea-pigs serum inhibits native IKr and prolong action potential
duration
Effect of serum samples from control scrambled peptide-immunized and serum samples from E-pore
peptide-immunized guinea-pigs on IKr (A and B, respectively) and action potentials (E and F, respectively) recorded
from guinea-pig ventricular myocytes. Averaged data from six experiments each for control and E-pore-immunized
guinea-pigs are represented by the histograms for IKr (C and D) and action potentials (G and H), respectively.
∗Statistical significance at P < 0.05 (n = 6 each).
Published 2016. This article is a U.S. Government work and is in the public domain in the USA
6182 F. Fabris and others J Physiol 594.21
(0.21± 0.04, n= 5 for immunized group and 0.18± 0.03,
n = 3 for control non-immunized; P = 0.129).
Mathematical simulation of the effects of anti-Ro
autoantibodies on repolarization currents and APD
The duration of theQT interval is determined by the APD,
which is controlled by threemajor repolarization currents,
IKr, IKs and ICaL. Previous experimental data from our
laboratory demonstrated that anti-Ro Abs inhibit both IKr
(Yue et al. 2015; Lazzerini et al. 2016) and ICaL (Boutjdir
et al. 1997, 1998; Xiao et al. 2001a) but not IKs (Xiao
et al. 2001a) when studied individually in expression
systems. Here, we used mathematical modelling of the
human ventricular AP developed by O’Hara et al. (2011)
to gain insight into changes in APD as a result of
both inhibition of individual currents and simultaneous
inhibition of IKr, IKs and ICaL. Figure 7 shows the results
of individual inhibition of IKr, IKs or ICaL by 20, 40, 60
and 100%. Only IKr inhibition resulted in pronounced
APDprolongation (Fig. 7A) that was ‘dose dependent’ and
consistent with recent experimental data (Yue et al. 2015).
For example, at 60% inhibition of IKr, APD90 lengthened
by 56.3%, whereas 100% inhibition of IKs resulted in only
6.5% prolongation of APD90, consistent with published
reports that IKs inhibition in the absence of sympathetic
stimulation plays little role in increasing normal human
AP repolarization (Jost et al. 2005). Although inherited
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Figure 5. Reactivity of serum samples from patients to E-pore
peptide assessed by enzyme-linked immunosorbent assay
Anti-Ro antibody-positive serum samples from patients with
connective tissue diseases and QTc prolongation had significant
(P < 0.001, n = 13) reactivity to E-pore peptide (left) compared with
anti-Ro antibody-negative serum samples from patients with
connective tissue diseases but with normal QTc (n = 8, right).
mutations in IKs channel protein are associated with
the occurrence of long QT1 (LQT1), it is known that
penetrance is low (Swan et al. 1998) in families with
documented LQT1 mutations, histories of seizures and
sudden cardiac death; and elevated sympathetic tone
may play a role in the phenotype expression. Note that
100% IKr inhibition resulted in an AP which did not
repolarize. In contrast, inhibition of ICaL shortened APD90
in a ‘dose-dependent’ manner. Inhibition of ICaL by 60%
resulted in only 16.3% shortening of APD90. Table 1
summarizes the percentage changes in ADP90 values as
a result of inhibition of individual currents.
Figure 8A shows the consequences of simultaneous
inhibition of IKr and ICaL on APD. Given that ICaL
inhibition antagonizes IKr inhibition vis-a`-vis APD, in this
simulation we kept IKr inhibition constant and evaluated
the effects of various degrees of ICaL inhibition (50, 80, 90
and 100%) on APD90. Inhibition of IKr by 50% resulted in
APD90 prolongation by 42.5% (Table 2), and additional
incremental inhibition of ICaL by 50, 80, 90 and 100%
prolonged APD90 by only 30.9, 18.4, 13.2 and 0.4%,
respectively (Table 2), suggesting that dual inhibition
of IKr and ICaL will dictate the net APD and thus QT
interval depending on the degree to which IKr and ICaL
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Non-Immunized
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Figure 6. Immunization of guinea-pigs with E-pore peptide
does not cause fibrosis
Masson’s Trichrome-stained sections from a non-immunized control
(A) and E-pore peptide-immunized (B) hearts from two different
guinea-pigs. No significant difference (P = 0.129) in fibrosis (blue
staining) was observed on day 62 after immunization in five hearts
compared with three control hearts (C). In Y axis, fibrosis is indicated
as percent of the affected area.
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conductances are inhibited. This is clinically relevant
because anti-Ro Abs inhibit both IKr (Yue et al. 2015;
Lazzerini et al. 2016) and ICaL (Boutjdir et al. 1997).
Finally, we explored the consequences of different degrees
of IKr inhibition and APD prolongation on QT interval.
This was achieved by simultaneous simulation of APD
and pseudo-ECG. Figure 8B and C demonstrates that
‘dose-dependent’ inhibition of IKr results in prolongation
not only of APD but also of QT interval, thereby
highlighting the direct relationship between IKr inhibition,
APD and QT prolongation on the surface ECG.
Discussion
The data from this study establish that immunization
of guinea-pigs with a peptide corresponding to the
extracellular loop at the pore region between S5 and
S6 (E-pore peptide) of the HERG channel generated
high titres of anti-E-pore peptide-inhibitory Abs, which
inhibited IKr from both the expressed and the native
HERG channel, and induced QTc prolongation on
the surface ECG in the absence of significant fibrosis.
These electrophysiological effects were not seen with
a control scrambled form of the E-pore peptide. In
addition, anti-Ro-positive serum samples from patients
with autoimmune diseases and QTc prolongation showed
significant reactivity to the E-pore peptide compared
with serum samples from control patients with auto-
immune diseases who were anti-Ro Ab negative and
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Figure 7. Computational model of the human ventricular
action potential
The conductances of IKr (A), IKs (B) and ICaL (C) were inhibited
individually to mimic autoantibody-induced inhibition of these
currents and to assess their impact on the action potential duration
at 90% (APD90). As can be seen, although inhibition of IKs had little
effect on APD, inhibition of IKr and ICaL resulted in marked
prolongation and shortening of APD, respectively.
Table 1. Mathematical model of the human cardiac action
potential: consequences of individual IKr, IKs and ICaL block on
action potential duration
Current 20% block 40% block 60% block 100% block
Percentage of APD90 changes for:
IKr +13.3 +31.6 +56.3 n.a.
IKs +1 +2.4 +3.8 +6.5
ICaL −5.1 −10.4 −16.3 −32
Key: ‘+’ indicates lengthening and ‘−’ indicates shortening of
the action potential at 90% duration (APD90); n.a. indicates that
the action potential did not repolarize.
had normal QTc. Mathematical simulation of major
repolarizing current inhibition by anti-Ro Abs suggests
that simultaneous inhibition of IKr and ICaL could account
for the variability of QTc prolongation in anti-Ro-positive
patients with autoimmune diseases. Altogether, these data
identify the extracellular loop pore region of the HERG
channel as an antigenic target for anti-Ro Abs, consistent
with the inhibition of IKr and the resulting prolongation
of AP and QTc in patients with autoimmune diseases.
Ro antigen is an intracellular ribonucleoprotein that
is not accessible to circulating anti-Ro Abs found in
multiple autoimmune diseases, including connective
tissue diseases, and is associated with QTc prolongation
in these patients (Lazzerini et al. 2004, 2007). Recently, we
established an animal model for anti-Ro Ab-associated
QTc prolongation (Yue et al. 2015) reminiscent of
the clinical phenotype and provided biochemical and
functional evidence that the HERG channel is a target for
these Abs. Given that Ro antigen is not normally accessible
to circulating antibodies, we postulated that a potential
epitope mimic is present on the HERG channel. Indeed,
homologybetweenRo52antigenand thepore regionof the
HERG channel was recently identified (Yue et al. 2015),
thereby accounting for the interaction between the Abs
and the HERG channel.
Linear homology analysis showed that there is 44%
homology between Ro52 protein (amino acids 302–321)
and the HERG α1 subunit (amino acids 574–598) at
the pore region, of which 25% are identical (Yue et al.
2015). The presence of this homology at the pore region
is potentially sufficient for anti-Ro52 Abs to bind to the
HERG channel at this epitope mimic, especially in the
tetrameric conformation of the channel, where the four
pore extracellular loops come together and are accessible
to the Abs (Fig. 1).
The present data demonstrating the induction of
QTc prolongation by immunization of guinea-pigs
with the E-pore peptide, but not with the scrambled
control peptide, establishes this HERG channel region
as a potential pathogenic epitope that serves as an
antigenic target for the circulating anti-Ro Abs. The
Published 2016. This article is a U.S. Government work and is in the public domain in the USA
6184 F. Fabris and others J Physiol 594.21
translational application of this finding is the potential
for the development of short therapeutic decoy biologics
that can distract pathogenic anti-Ro Abs from the HERG
channel, thereby preventing the interaction and thus QTc
prolongation. To date, it is not clear what specific sequence
on the Ro52 antigen is responsible for immunogenicity
in patients with autoimmune diseases. In fact, although
some groups identified the central part of the antigen
(i.e. the coiled-coil domain), particularly the p200 peptide
(amino acids 200–239), as the main immunogenic region
(Bozic et al. 1993; Salomonsson et al. 2002; Strandberg
et al. 2008; Burbelo et al. 2010; Infantino et al. 2015),
others did not confirm these findings, demonstrating a
prevalent reactivity towards sequences included in the
N-terminal (RING-B-box domain) and C-terminal parts
(B30.2. domain) of the antigen (Fritsch et al. 2006).
Hennig et al. (2008) found that in patients with Sjogren’s
syndrome, a native autoantigenic epitope is located in the
zinc-binding region of the RING-B-box domain. Other
studies reported a significant immunogenicity also in
the B30.2 domain able to generate high antibody titres
in patients with autoimmune diseases, particularly when
affected by Sjo¨gren’s syndrome (Bozic et al. 1993; Burbelo
et al. 2010; Infantino et al. 2015). Notably, the C-terminal
B30.2 domain contains the amino acid sequence (amino
acids 302–321) that overlaps with HERG. Future in vivo
studies are needed to develop non-pathological peptides
able to serve as effective decoys and neutralize the
pathogenic Abs.
The QTc prolongation observed in the E-pore
peptide-immunized guinea-pigs correlated with the
development of the antibody titre. This is consistent
with the in vitro and clinical data demonstrating the
dose-dependent inhibition of HERG channels (Yue
et al. 2015) and the titre-dependent association between
anti-Ro52 Abs and QTc prolongation (Lazzerini et al.
2011). These observations may account, in part, for
individual variability in QTc prolongation observed in
patients with autoimmune diseases (Lazzerini et al. 2004,
2007, 2011). Indeed, among those patients presenting
with QTc prolongation, QTc can vary from 460 to >560
ms (Lazzerini et al. 2004, 2007, 2011). In this regard,
only patients with a moderate to high concentration
(50 U ml−1) of circulating anti-Ro52 Abs exhibit QTc
prolongation (Lazzerini et al. 2011).
The titre-dependent associationwithQTc prolongation
cannot alone account for the variability in QTc
prolongation, because dual inhibition of HERG and
L-type Ca2+ channels could be another contributory
factor. The current generated through the HERG channel,
IKr, repolarizes the AP, and its inhibition lengthens the
APD and QT interval. However, the current generated
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Figure 8. Computational model of the human
ventricular action potential and pseudo-ECG
A, simultaneous inhibition of IKr conductance at 50% and
ICaL conductance at 50, 80, 90 and 100% was simulated
to assess the overall changes in the action potential
duration at 90% (APD90). Inhibition of IKr (50%) resulted
in a significant prolongation in APD90 (red action
potential). Incremental inhibition of ICaL, in addition to
IKr, resulted in progressive shortening of APD90 but did
not exceed (blue action potential) the control APD90
(black action potential). The consequences of IKr
conductance inhibition in a dose-dependent manner
resulted not only in action potential prolongation (B) but
also in QT interval prolongation on the pseudo-ECG (C).
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Table 2. Mathematical model of the human cardiac action potential: consequences of simultaneous inhibition of IKr and ICaL on action
potential duration
Percentage of IKr Percentage of ICaL Percentage APD90
inhibition inhibition APD90 changes
Control 0 0 264.35 0
Simulation 1 50 0 376.74 42.5
Simulation 2 50 50 345.96 30.5
Simulation 3 50 80 313.11 18.4
Simulation 4 50 90 299.24 13.2
Simulation 5 50 100 265.36 0.4
Abbreviations: APD90, action potential duration at 90%.
through L-type Ca2+ channels, ICaL, delays repolarization,
and its inhibition shortens theAPD.As such, simultaneous
inhibition of both IKr and ICaL has opposite effects
on APD, and the net outcome will depend on the
relative degree of IKr and ICaL inhibition by the Abs.
To this end, the mathematical simulation data suggest
that although inhibition of ICaL shortens APD, thereby
antagonizing ADP prolongation due to IKr inhibition,
which per se seems predominant and leads to more
dramatic prolongation of APD. As shown in Fig. 8, the
net APD and QT interval durations are determined by
the degree of IKr and ICaL inhibition by the Abs titre
level in a given patient; however, the scenario of 100%
ICaL inhibition by the Abs is unlikely, because we have
previously shown that anti-Ro Abs inhibit ICaL by only
40–60%maximum(Boutjdir et al.1997, 1998).Altogether,
the Ab titre combinedwith the balance between the degree
of IKr and ICaL inhibition by Abs will determine the APD
and QTc durations and thus could also contribute to the
variability of QTc values in patients with autoimmune
diseases.
Nakamura and colleagues, in their elegant study
(Nakamura et al. 2007), also showed that anti-Ro
Ab-positive serum and purified IgG, from a female patient
(n = 1) with marked QTc and episodes of torsades
de pointes, functionally inhibited and biochemically
interacted with the HERG channel proteins in a
dose-dependent manner. These effects were observed
only when HEK293 cells in culture were incubated with
anti-Ro-positive serum and purified IgG for 1–5 days, but
no acute effects (5 min) were observed. In contrast, the
data from the present study and other studies from our
group (Yue et al. 2015; Lazzerini et al. 2016) demonstrated
a consistent inhibitory effect on IKr within minutes.
Specifically, anti-Ro Ab-positive IgG from a total of 10
patients from two different studies (Yue et al. 2015;
Lazzerini et al. 2016) each tested in several HEK293 cells
(n= 6 each) consistently showed a time-dependent effect,
with a steady state reached within 8–12min. It is therefore
possible that longer periods of time than the 5 min
exposure in the study by Nakamura et al. (2007) may
have been necessary to see an acute effect similar to the
one reported in our experimental conditions. The fact that
the study by Nakamura et al. (2007) used only one patient
may also have contributed to their findings. Differences in
the experimental conditions between the two studies may
also, at least in part, have contributed to the differences
seen, because no detailed methodology was provided in
the the study by Nakamura et al. (2007). Nevertheless,
both studies showed that anti-Ro Abs inhibit IKr.
Collectively, the findings from the present study are
the first to demonstrate that inhibitory antibodies to the
HERG E-pore region peptide but not to HERG E-pore
region scrambled peptide induce QTc prolongation
in immunized guinea-pigs by targeting the HERG
channel independently from fibrosis. Furthermore, the
reactivity of anti-Ro Ab-positive sera from patients
with connective tissue diseases with the E-pore peptide
opens novel pharmacotherapeutic avenues in the
diagnosis and management of autoimmune-associated
QTc prolongation.
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